Compare ATON & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATON | TNON |
|---|---|---|
| Founded | 1973 | 2012 |
| Country | British Virgin Islands | United States |
| Employees | 4 | 27 |
| Industry | Oil & Gas Production | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3M | 7.6M |
| IPO Year | N/A | N/A |
| Metric | ATON | TNON |
|---|---|---|
| Price | $0.33 | $0.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 763.1K | 86.5K |
| Earning Date | 07-24-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $65.95 |
| Revenue Next Year | N/A | $50.54 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.28 | $0.64 |
| 52 Week High | $13.80 | $2.48 |
| Indicator | ATON | TNON |
|---|---|---|
| Relative Strength Index (RSI) | 44.61 | 51.40 |
| Support Level | $0.28 | $0.66 |
| Resistance Level | $0.35 | $0.88 |
| Average True Range (ATR) | 0.03 | 0.03 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 71.54 | 54.66 |
AlphaTON Capital Corp is a specialized digital asset treasury company focused on building and managing a strategic reserve of TON tokens and developing the Telegram ecosystem. The company implements a comprehensive treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, it provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.